2,3,4,5-TETRAHYDRO-1H-BENZO[E][1,4]DIAZEPIN-8-YLAMINE 2HCL, 97.0%, 5g

3-Methoxy-4-cyclopropylbromobenzene, 95%, 100mg

2-Bromo-4-(trifluoromethyl)benzyl alcohol, 95.0%, 5g

5-Bromo-6-fluoro-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 5g

3-Hexanone>98.0%(GC)25mL

(S)-1-(3-Chlorophenyl)-2,2,2-trifluoroethan-1-amine hydrochloride, 95%, 250mg

2-Methoxy-5-formylphenylboronic acid, 98.0%, 5g

S-(7-Oxo-7-((4-phenylthiazol-2-yl)amino)heptyl) 2-methylpropanethioate, 95.0%, 10mg

3-Chloro-2-methoxy-5-nitropyridine, 95.0%, 1g

2-Furaldehyde diethyl acetal, 95.0%, 25g

3-((2,5-Dichloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)propan-1-ol, 100mg

(2-Ethoxy-3-formyl-5-methylphenyl)boronic acid, 95%, 1g

2-(2-Aminoethylamino)ethanol, min. 98%, for synthesis, 500 ml, glass packaging